Archive


Category: Cheng Zhang

  • Clover Therapeutics turns a new leaf as Character Bio to pursue dry AMD & more

    Dry age-related macular degeneration currently has no FDA-approved treatments but the research of Clover Therapeutics has yielded two candidates. The biotech startup has made progress in the past two years under CEO Cheng Zhang and it’s now revealing more details about its approach, a new corporate identity, and a Series A financing that puts it […]